CTNNB1 and neoplasm: Accordingly, analysis of the RNA sequencing data showed relatively higher levels of expression of β-catenin and Wnt/β-catenin targets in tumours with either the CTNNB1 p.I35T or FBXW11 p.F517S mutation compared to those without these mutations (Supplementary Fig. 11).